Ionis Pharmaceuticals | IONS - Operating Expenses


Ionis Pharmaceuticals reported $364M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agios Pharmaceuticals USD 130.77M 10.77M Mar/2026
Alnylam Pharmaceuticals USD 898.54M 66.78M Mar/2026
Arrowhead Research USD 215M 8.23M Mar/2026
Astellas Pharma JPY 489.36B 52.69B Mar/2026
BioCryst Pharmaceuticals USD -553.84M 700.01M Mar/2026
BioMarin Pharmaceutical USD 636.56M 39.61M Mar/2026
Celltrion KRW 119.22B 21.46B Mar/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Exelixis USD 359.47M 3.28M Mar/2026
Halozyme Therapeutics USD 192.19M 18.88M Mar/2026
Ionis Pharmaceuticals USD 364M 54M Mar/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Moderna USD 1.78B 242M Mar/2026
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Neurocrine Biosciences USD 599.9M 22.3M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Omeros USD 59.16M 20.13M Jun/2024
OPKO Health USD 175.21M 11.55M Mar/2026
Organigram Holdings CAD 69.59M 14.08M Mar/2026
Ovoca Bio EUR 1.16M 4.48M Jun/2025
Pfizer USD 90.1B 77.19B Mar/2026
Pharma Mar EUR 42.28M 4.59M Mar/2026
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Qiagen NV USD 418.54M 23.25M Dec/2025
Regeneron Pharmaceuticals USD 31.42B 28.44B Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sarepta Therapeutics USD 372.37M 480.65M Mar/2026
Sartorius EUR 738.4M 22.4M Mar/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tilray USD 237.52M 17.34M Sep/2025
Ultragenyx Pharmaceutical USD 305M 16M Mar/2026
Vertex Pharmaceuticals USD 1.85B 78.6M Mar/2026
Zealand Pharma A/S 775.97M 265.08M Dec/2025
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026